Enhanced Brain Biodistribution of GLP-1 Drugs May Be Related to Improvements in Safety and Efficacy   Kelowna, British Columbia – September 19, 2025 – TheNewswire - Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce successful results from its fluorescently tagged semaglutide (“FTS”) rodent biodistribution study (the “Study”). The main goal of the Study was to determine whether the DehydraTECH processing of sem ...